ACUTE PSYCHOSIS WITH CARBAMAZEPINE AND SODIUM VALPROATE

The Lancet

Volumn 333, Issue 8630, 1989, Pages 167-

  Mckee, R J W ^a   Larkin, J G ^a   Brodie, M J ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; VALPROIC ACID;

ADULT; EPILEPSY; HUMAN; LETTER; MALE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PSYCHOSIS;

ACUTE DISEASE; ADULT; CARBAMAZEPINE; CASE REPORT; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; EPILEPSY, TEMPORAL LOBE; HUMAN; MALE; PSYCHOSES, SUBSTANCE-INDUCED; VALPROIC ACID;

EID: 0024501725     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(89)91190-2     Document Type: Letter

References (10)

1. The optimum use of anticonvulsants
2. Carbamazepine in treatment of violent schizophrenics
3. Carbamazepine vs lithium in the treatment and prophylaxis of mania
4. Psychiatric symptoms associated with carbamazepine
5. Practical clinical pharmacology: therapeutic drug monitoring and clinical trials
6. An unusual manifestation of carbamazepine toxicity
7. Behavioural effect of anti-epileptic drugs
8. Schizophrenia-like psychosis associated with anticonvulsant toxicity
9. Side effects induced by carbamazepine-10,11-epoxide
10. Effect of sodium valproate on carbamazepine disposition and psychomotor profile in man